mRNA |
lapatinib |
CCLE |
pan-cancer |
AAC |
-0.021 |
0.7 |
mRNA |
WZ-1-84 |
GDSC1000 |
pan-cancer |
AAC |
0.024 |
0.7 |
mRNA |
UNC0638 |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.7 |
mRNA |
ciclosporin |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.7 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.7 |
mRNA |
BRD-K16130065 |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.7 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.7 |
mRNA |
Zibotentan |
GDSC1000 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
Vandetanib |
CCLE |
pan-cancer |
AAC |
0.021 |
0.7 |